Identification of respiratory isolates of Stenotrophomonas maltophilia by commercial biochemical systems and species-specific PCR

被引：5

作者：

Giordano, A

Magni, A

Trancassini, M

Varesi, P

Turner, R

Mancini, C

机构：

[1] Univ Roma La Sapienza, Dipartimento Sci Sanita Pubbl, Sez Microbiol, I-00136 Rome, Italy

[2] BioMerieux Italia, Rome, Italy

来源：

JOURNAL OF MICROBIOLOGICAL METHODS | 2006年 / 64卷 / 01期

关键词：

identification; biochemical; molecular; Stenotrophomonas maltophilia;

D O I：

10.1016/j.mimet.2005.04.020

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

One hundred strains of Stenotrophomonas maltophilia isolates from respiratory specimens were biochemically identified using the API 20NE strip and the VITEK (R) 2 ID-GNB card. The identification was confirmed by a species-specific PCR using two primers specific for the 23S rRNA gene. The API 20NE showed only I strain with "low discrimination" whereas the VITEK (R) 2 gave 12. In any case.. the two biochemical systems showed good reliability compared to SS-PCR. (c) 2005 Elsevier B.V. All rights reserved.

引用

收藏

页码：135 / 138

页数：4

相关论文

共 15 条

[1] Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomas maltophilia [J].

Berg, G ;

Roskot, N ;

Smalla, K .

JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (11) :3594-3600

[2] Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia [J].

Denton, M ;

Kerr, KG .

CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (01) :57-+

[3]

ELTING LS, 1990, INFECT CONT HOSP EP, V11, P134

[4] Evaluation of the VITEK 2 system for rapid identification of medically relevant gram-negative rods [J].

Funke, G ;

Monnet, D ;

deBernardis, C ;

von Graevenitz, A ;

Freney, J .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) :1948-1952

[5] Stenotrophomonas maltophilia: Emergence of multidrug-resistant strains during therapy and in an in vitro pharmacodynamic chamber model [J].

Garrison, MW ;

Anderson, DE ;

Campbell, DM ;

Carroll, KC ;

Malone, CL ;

Anderson, JD ;

Hollis, RJ ;

Pfaller, MA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2859-2864

[6] Factors affecting the incidence Stenotrophomonas maltophilia isolation in cystic fibrosis [J].

Graff, GR ;

Burns, JL .

CHEST, 2002, 121 (06) :1754-1760

[7] Risk factors for late-onset nosocomial pneumonia caused by Stenotrophomonas maltophilia in critically ill trauma patients [J].

Hanes, SD ;

Demirkan, K ;

Tolley, E ;

Boucher, BA ;

Croce, MA ;

Wood, GC ;

Fabian, TC .

CLINICAL INFECTIOUS DISEASES, 2002, 35 (03) :228-235

[8] Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis [J].

Krzewinski, JW ;

Nguyen, CD ;

Foster, JM ;

Burns, JL .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3597-3602

[9] MOLECULAR EPIDEMIOLOGY OF XANTHOMONAS-MALTOPHILIA COLONIZATION AND INFECTION IN THE HOSPITAL ENVIRONMENT [J].

LAING, FPY ;

RAMOTAR, K ;

READ, RR ;

ALFIERI, N ;

KUREISHI, A ;

HENDERSON, EA ;

LOUIE, TJ .

JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (03) :513-518

[10] Evaluation of VITEK 2 rapid identification and susceptibility testing system against Gram-negative clinical isolates [J].

Ling, TKW ;

Tam, PC ;

Liu, ZK ;

Cheng, AFB .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (08) :2964-2966